The Effects of Dexmedetomidine to Postoperative Awakening and Extubation-related Changes in Blood Pressure

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Hypertension
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine will be diluted into a saline solution to a recommended concentration of 4 micrograms per millilitre. The saline will then be initially administered at the rate of 0.5 micrograms/kg/h and from that point the amount will be reduced to the point where the patient breathes well and is calm (compare dexmedetomidine recommendation at 0.2-1.4 ug/kg/h). The infusion rate will then be approximately 1-10 ml/h for a patient of 80 kgs weight. The exact dosage cannot be predetermined because it differs in each individual. In the control group the infusion speed is matching.

OTHER

Saline (placebo)

Saline placebo infusion will be adjusted the same fashion as the active comparator drug.

Trial Locations (1)

33521

TAYS Sydänkeskus Oy (Heart Center CO. Tampere University Hospital), Tampere

All Listed Sponsors
lead

Tampere University Hospital

OTHER

NCT01871129 - The Effects of Dexmedetomidine to Postoperative Awakening and Extubation-related Changes in Blood Pressure | Biotech Hunter | Biotech Hunter